Latest Schedule 13G passive stakes

MMCAP International Inc. SPC and MM Asset Management Inc. have jointly reported beneficial ownership of 2,550,000 common shares, representing 8.5% of Thunder Bridge Capital Partners V, Ltd.

Clear Street Derivatives LLC has reported beneficial ownership of 12.0% of Kartoon Studios Inc. common stock as of June 30, 2026.

Cobas Asset Management, SGIIC, S.A. has disclosed beneficial ownership of 31,331,960 common shares, representing 10.2% of the class, in Borr Drilling Ltd.

Key individuals and entities associated with Creative Global Technology Holdings Ltd report a combined beneficial ownership of 36.26% of the company's Class A and Class B ordinary shares following a recent reverse stock split.

Francisco Trust reports a 10.32% ownership in Dyadic International Inc., including shares convertible from a promissory note.

Jared Kelly has updated his Schedule 13G filing, reporting beneficial ownership of 4.7% of MarketWise, Inc.'s Class A Common Stock as of April 7, 2026.

L.I.A. Pure Capital Ltd. has filed an amendment to its Schedule 13G, reporting a beneficial ownership stake of 6.83% in Rail Vision Ltd.

Polar Asset Management Partners Inc. has disclosed beneficial ownership of 13.6% of Aeon Acquisition I Corp.'s Class A Ordinary Shares as of June 30, 2026.

Polar Asset Management Partners Inc. has filed a Schedule 13G, reporting beneficial ownership of 174,303 shares of Bitcoin Depot Inc. Class A Common Stock, representing 2.9% of the class, primarily through warrants and call options.

Coliseum Capital Management and affiliated entities have increased their beneficial ownership of MasterBrand, Inc. common stock to 6.5%, holding over 13.2 million shares.

Coliseum Capital Management, LLC and affiliated entities have filed a Schedule 13G, reporting beneficial ownership of 3.3% of Herc Holdings Inc. common stock.

Polar Asset Management Partners Inc. has disclosed beneficial ownership of 5.6% of Blaize Holdings, Inc. common stock, acquiring 9,375,000 shares.

Polar Asset Management Partners Inc. has disclosed beneficial ownership of 1,150 Class A Ordinary Shares, representing 5.2% of the class, in Collective Acquisition Corp. II.

Polar Asset Management Partners Inc. has disclosed beneficial ownership of 8.9% of Disciplined Growth Acquisition Corp's Class A Ordinary Shares as of June 30, 2026.

Polar Asset Management Partners Inc. has disclosed beneficial ownership of 5.0% of Harvard Ave Acquisition Corp.'s Class A Ordinary Shares, signaling a notable investment position.

Polar Asset Management Partners Inc. has disclosed a beneficial ownership of 1,000,000 Class A Ordinary Shares, representing 6.3% of the class, in Iron Dome Acquisition I Corp.

Polar Asset Management Partners Inc. has disclosed beneficial ownership of 5.0% of Oceanhawk Acquisition Corp.'s Class A Ordinary Shares, totaling 950,000 shares.

Polar Asset Management Partners Inc. has disclosed beneficial ownership of 1,200,000 Class A Ordinary Shares, representing 5.2% of the class, in Wilco 63 Corp.

Polar Asset Management Partners Inc. has disclosed beneficial ownership of 7.0% of Incannex Healthcare Inc.'s common stock, acquiring 900,000 shares via warrants.

Polar Asset Management Partners Inc. has disclosed beneficial ownership of 1,965,000 Class A Ordinary Shares, representing 8.3% of the class, in GSR V Acquisition Corp.

Hivemind Capital Partners, LLC and its affiliates have disclosed a beneficial ownership stake of 9.99% in Upexi, Inc., primarily through common stock, pre-funded warrants, and a convertible note.

Hivemind Capital Partners, along with affiliated entities, has reported beneficial ownership of 6,841,923 shares of Upexi, Inc. common stock, representing 9.99% of the outstanding shares.

ADAR1 Capital Management, LLC and Daniel Schneeberger have filed a joint Schedule 13G statement regarding their beneficial ownership of NextCure, Inc. common stock.

ADAR1 Capital Management, LLC and Daniel Schneeberger have jointly filed a Schedule 13G, reporting beneficial ownership of 8.8% of Yarrow Bioscience, Inc. common stock as of June 30, 2026.

ADAR1 Capital Management, LLC and its manager Daniel Schneeberger have jointly filed a Schedule 13G, reporting beneficial ownership of 4,500,000 shares, representing 5.3% of Rein Therapeutics, Inc.'s common stock as of June 30, 2026.

Merus Global Investments, LLC has filed an amendment to its Schedule 13G, reporting a complete divestment of its holdings in General Fusion Group Ltd.

ADAR1 Capital Management, LLC and Daniel Schneeberger have jointly filed a Schedule 13G, reporting beneficial ownership of 8.4% of Research Alliance Corporation III's Class A Ordinary Shares.

ADAR1 Capital Management, LLC and Daniel Schneeberger have jointly filed a Schedule 13G, reporting beneficial ownership of 8.9% of Pliant Therapeutics, Inc. common stock as of June 30, 2026.

ADAR1 Capital Management, LLC and its manager Daniel Schneeberger have jointly filed a Schedule 13G, reporting beneficial ownership of 417,724 Ordinary Shares, representing 5.4% of the outstanding shares of JATT II Acquisition Corp.

ADAR1 Capital Management, LLC and Daniel Schneeberger have jointly filed a Schedule 13G, reporting beneficial ownership of 5.8% of Editas Medicine, Inc. common stock as of June 30, 2026.